Teenagers who regularly have headaches may find that their problem is linked to overweight, smoking and/or lack of physical exercise, according to an article published in the medical journal Neurology. The authors found that teenagers with all three factors - those who were overweight, smoked and did very little exercise - were 3.4 more likely to suffer from recurring headaches, compared to individuals of their age who did not smoke, were physically active and were not overweight…

Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. Teens with all three of the negative lifestyle factors were 3.4 times more likely to have frequent headaches than those with none of the negative lifestyle factors…

Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009. “The approval and subsequent commercialization of CAMBIA as a unique formulation of diclofenac offers an important treatment option for the millions of people who suffer from migraines,” said Alan M. Rapoport, M.D…

A migraine is not your average headache. The pain of a migraine may feel dull, deep, intense or throbbing. That pain often sends migraine sufferers in search of a dark, quiet place to lie down. Untreated, migraines can last from four to 72 hours. The April issue of Mayo Clinic Women’s HealthSource provides an overview of migraine prevalence, causes, triggers, treatments and prevention

When people feel the onset of a migraine headache, they may head to a dark, quiet room to rest. This instinct may be sound: A new study suggests that even without the headache, migraine sufferers may process visual cues better in an environment with few visual distractions…

Research published ahead of print in the Journal of Neurology Neurosurgery and Psychiatry reports that chronic migraine sufferers tend to be in poorer general health, less wealthy, and more depressed than those with episodic migraine. Episodic migraine is a severe headache happening up to 14 days of the month. Chronic migraine is headache happening 15 or more days of the month. The findings are based on data of approximately 12,000 adults with episodic and chronic migraines. All participants were already part of the American Migraine Prevalence and Prevention (AMPP) study…

Trigemina, Inc. (TI), a Mountain View based startup, has begun a Phase IIa clinical trial for its lead molecule in Chronic Daily Headache (CDH) in collaboration with Dr. Egilius Spierings at MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from at least 15 days of headache pain per month. CDH represents approximately 3% of the US population for which there currently is no effective treatment…

UroToday.com - Childhood maltreatment is prevalent and has been associated with a wide range of adult psychiatric and physical disorders. Many studies have focused on the relationship of abuse with depression and anxiety, 2 conditions strongly associated with chronic pain syndromes.

Addex Pharmaceuticals (SWISS: ADXN) announced that it has decided to end prematurely the migraine prevention study 206. Routine safety monitoring of blinded data in study 206 has revealed an incidence of abnormalities of liver function tests that is higher than expected in this population. The abnormalities are apparent from day 28 of dosing but the incidence and severity appear to increase progressively with increasing duration of participation in the study…

Patients with a cluster headache, which is characterized by bouts of excruciating pain usually near the eye or temple, were more likely to report being pain-free within 15 minutes of treatment with high-flow oxygen than patients who received a placebo treatment, according to a study in the December 9 issue of JAMA. Cluster headache attacks typically last for 15 minutes to 3 hours untreated and have a frequency of 1 every other day for up to 8 attacks a day…